- Home
- ZUO vs WGS Comparison
ZUO vs WGS Comparison
Compare ZUO & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUO
- WGS
- Stock Information
- Founded
- ZUO 2006
- WGS 2017
- Country
- ZUO United States
- WGS United States
- Employees
- ZUO N/A
- WGS N/A
- Industry
- ZUO EDP Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- ZUO Technology
- WGS Technology
- Exchange
- ZUO Nasdaq
- WGS Nasdaq
- Market Cap
- ZUO 1.4B
- WGS 1.5B
- IPO Year
- ZUO 2018
- WGS N/A
- Fundamental
- Price
- ZUO $9.90
- WGS $68.43
- Analyst Decision
- ZUO Buy
- WGS Strong Buy
- Analyst Count
- ZUO 7
- WGS 5
- Target Price
- ZUO $11.43
- WGS $67.00
- AVG Volume (30 Days)
- ZUO 3.4M
- WGS 753.8K
- Earning Date
- ZUO 11-27-2024
- WGS 10-29-2024
- Dividend Yield
- ZUO N/A
- WGS N/A
- EPS Growth
- ZUO N/A
- WGS N/A
- EPS
- ZUO N/A
- WGS N/A
- Revenue
- ZUO $445,683,000.00
- WGS $267,228,000.00
- Revenue This Year
- ZUO $7.45
- WGS $43.70
- Revenue Next Year
- ZUO $7.65
- WGS $16.78
- P/E Ratio
- ZUO N/A
- WGS N/A
- Revenue Growth
- ZUO 7.33
- WGS 29.41
- 52 Week Low
- ZUO $7.70
- WGS $1.29
- 52 Week High
- ZUO $10.85
- WGS $89.11
- Technical
- Relative Strength Index (RSI)
- ZUO 70.20
- WGS 51.05
- Support Level
- ZUO $9.85
- WGS $71.45
- Resistance Level
- ZUO $9.91
- WGS $82.18
- Average True Range (ATR)
- ZUO 0.04
- WGS 7.58
- MACD
- ZUO -0.04
- WGS -1.36
- Stochastic Oscillator
- ZUO 55.56
- WGS 17.21
About ZUO Zuora Inc.
Zuora Inc provides cloud-based software on a subscription basis that enables companies in various industries to launch, manage, and transform into a subscription business. The firm offers a Zuora Central platform that acts as an intelligent subscription management hub that automates the subscription order-to-cash process, including quoting, billing, collections, analytics, and revenue recognition. Its products include Zuora Billing, Zuora Revenue, Zuora Payments, Zephr, Zuora Platform, and other software that support and expand upon the core offerings. Geographically, it derives a majority of its revenue from the United States.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.